ATE215599T1 - Superoxid dismutase-4 - Google Patents
Superoxid dismutase-4Info
- Publication number
- ATE215599T1 ATE215599T1 AT94923172T AT94923172T ATE215599T1 AT E215599 T1 ATE215599 T1 AT E215599T1 AT 94923172 T AT94923172 T AT 94923172T AT 94923172 T AT94923172 T AT 94923172T AT E215599 T1 ATE215599 T1 AT E215599T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptide
- sod
- superoxide dismutase
- polypeptides
- nucleic acid
- Prior art date
Links
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/225,757 US5506133A (en) | 1994-04-11 | 1994-04-11 | Superoxide dismutase-4 |
| PCT/US1994/006099 WO1995027781A1 (en) | 1994-04-11 | 1994-05-31 | Superoxide dismutase-4 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE215599T1 true ATE215599T1 (de) | 2002-04-15 |
Family
ID=22846108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94923172T ATE215599T1 (de) | 1994-04-11 | 1994-05-31 | Superoxid dismutase-4 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US5506133A (de) |
| EP (2) | EP0775199B1 (de) |
| JP (2) | JPH09511648A (de) |
| CN (2) | CN1073154C (de) |
| AT (1) | ATE215599T1 (de) |
| AU (1) | AU683286B2 (de) |
| CA (1) | CA2187635A1 (de) |
| DE (1) | DE69430326T2 (de) |
| DK (1) | DK0775199T3 (de) |
| ES (1) | ES2173919T3 (de) |
| PT (1) | PT775199E (de) |
| WO (1) | WO1995027781A1 (de) |
| ZA (1) | ZA944039B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672509A (en) * | 1993-08-25 | 1997-09-30 | Pfizer Inc. | hPDE IV-C: a human phosphodiesterase IV isozyme |
| US5506133A (en) * | 1994-04-11 | 1996-04-09 | Human Genome Sciences, Inc. | Superoxide dismutase-4 |
| US20060223077A1 (en) * | 1997-06-06 | 2006-10-05 | Human Genome Sciences, Inc. | 207 human secreted proteins |
| FR2792000B1 (fr) * | 1999-04-08 | 2003-04-11 | Centre Nat Rech Scient | Procede de cartographie d'une molecule d'adn comprenant une etape d'amplification ad infinitum |
| WO2005069938A2 (en) * | 2004-01-20 | 2005-08-04 | The Regents Of The University Of California | Extracellular superoxide dismutase (ec-sod) gene delivery to prevent oxidative injury |
| DE102007010785A1 (de) * | 2007-03-02 | 2008-09-04 | Henkel Ag & Co. Kgaa | Verwendung von Superoxid-Dismutasen in Wasch- und Reinigungsmitteln |
| KR102593542B1 (ko) * | 2021-06-10 | 2023-10-26 | 씨제이제일제당 주식회사 | 슈퍼옥사이드 디스뮤테이즈 1 변이체 및 이를 이용한 글루타치온 또는 그 유도체의 생산방법 |
| CN116103253A (zh) * | 2023-01-10 | 2023-05-12 | 杭州浦泰生物科技有限公司 | 一种重组人超氧化物歧化酶及其制备方法和应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252476A (en) * | 1983-10-03 | 1993-10-12 | Chiron Corporation | Superoxide dismutase cloning and expression in microorganisms |
| US5162217A (en) * | 1984-08-27 | 1992-11-10 | Bio-Technology General Corp. | Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof |
| US5242794A (en) * | 1984-12-13 | 1993-09-07 | Applied Biosystems, Inc. | Detection of specific sequences in nucleic acids |
| US5248603A (en) * | 1985-09-03 | 1993-09-28 | Symbicom Aktiebolag | Superoxide dismutase |
| JPS62103026A (ja) * | 1985-10-28 | 1987-05-13 | Nikken Food Kk | Ｓｏｄ活性剤およびその製造法 |
| US4976959A (en) * | 1986-05-12 | 1990-12-11 | Burroughs Wellcome Co. | T-PA and SOD in limiting tissue damage |
| US4946778A (en) * | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| JPS6377822A (ja) * | 1986-09-18 | 1988-04-08 | Ube Ind Ltd | 臓器機能改善剤 |
| ATE132902T1 (de) * | 1987-03-14 | 1996-01-15 | Boehringer Ingelheim Int | Humane mangan-superoxiddismutase (hmn-sod) |
| JPS63313581A (ja) * | 1987-06-16 | 1988-12-21 | Ube Ind Ltd | 修飾ス−パ−オキシドジスムタ−ゼ |
| JPH02156884A (ja) * | 1988-12-10 | 1990-06-15 | Hagiwara Yoshihide | ポリペプチド及びその製造方法 |
| US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5360729A (en) * | 1989-11-07 | 1994-11-01 | Bio-Technology General Corp. | Method for purification of recombinant copper/zinc (CU-ZN) superoxide dismutase from bacteria or eucaryotic cells |
| IL96136A (en) * | 1989-11-07 | 2000-12-06 | Bio Technology General Corp | Use of hydrophobic chromatography in a method for purification of copper-zinc superoxide dismutase from cells containing same |
| US5219737A (en) | 1990-03-27 | 1993-06-15 | Kikkoman Corporation | Mutant luciferase of a firefly, mutant luciferase genes, recombinant dnas containing the genes and a method of producing mutant luciferase |
| JPH04108379A (ja) * | 1990-08-28 | 1992-04-09 | Suntory Ltd | 新規スーパーオキサイドディスムターゼ |
| AU8947791A (en) * | 1990-11-01 | 1992-05-26 | Scripps Research Institute, The | Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
| JPH04248984A (ja) * | 1991-02-05 | 1992-09-04 | Kuraray Co Ltd | スーパーオキシドジスムターゼ誘導体およびその製造方法 |
| JPH04312533A (ja) * | 1991-04-09 | 1992-11-04 | Nippon Kayaku Co Ltd | 脳虚血症治療剤 |
| JPH04327541A (ja) * | 1991-04-23 | 1992-11-17 | Nippon Kayaku Co Ltd | 拒絶反応による移植臓器障害治療剤 |
| US5506133A (en) * | 1994-04-11 | 1996-04-09 | Human Genome Sciences, Inc. | Superoxide dismutase-4 |
-
1994
- 1994-04-11 US US08/225,757 patent/US5506133A/en not_active Expired - Lifetime
- 1994-05-31 DK DK94923172T patent/DK0775199T3/da active
- 1994-05-31 ES ES94923172T patent/ES2173919T3/es not_active Expired - Lifetime
- 1994-05-31 CN CN94195125A patent/CN1073154C/zh not_active Expired - Fee Related
- 1994-05-31 AT AT94923172T patent/ATE215599T1/de not_active IP Right Cessation
- 1994-05-31 JP JP7526308A patent/JPH09511648A/ja active Pending
- 1994-05-31 PT PT94923172T patent/PT775199E/pt unknown
- 1994-05-31 CA CA002187635A patent/CA2187635A1/en not_active Abandoned
- 1994-05-31 DE DE69430326T patent/DE69430326T2/de not_active Expired - Fee Related
- 1994-05-31 US US08/722,050 patent/US5871729A/en not_active Expired - Fee Related
- 1994-05-31 AU AU73123/94A patent/AU683286B2/en not_active Ceased
- 1994-05-31 EP EP94923172A patent/EP0775199B1/de not_active Expired - Lifetime
- 1994-05-31 EP EP01120917A patent/EP1158046A1/de not_active Withdrawn
- 1994-05-31 WO PCT/US1994/006099 patent/WO1995027781A1/en not_active Ceased
- 1994-06-08 ZA ZA944039A patent/ZA944039B/xx unknown
-
2001
- 2001-02-20 CN CN01104081A patent/CN1332240A/zh active Pending
- 2001-05-30 JP JP2001163501A patent/JP2002085082A/ja active Pending
- 2001-06-20 US US09/883,985 patent/US6635252B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5871729A (en) | 1999-02-16 |
| US5506133A (en) | 1996-04-09 |
| US20020081288A1 (en) | 2002-06-27 |
| JPH09511648A (ja) | 1997-11-25 |
| ES2173919T3 (es) | 2002-11-01 |
| DE69430326T2 (de) | 2002-11-07 |
| EP1158046A1 (de) | 2001-11-28 |
| DE69430326D1 (de) | 2002-05-08 |
| DK0775199T3 (da) | 2002-06-03 |
| EP0775199B1 (de) | 2002-04-03 |
| CA2187635A1 (en) | 1995-10-19 |
| ZA944039B (en) | 1995-12-08 |
| CN1152337A (zh) | 1997-06-18 |
| EP0775199A4 (de) | 1997-12-03 |
| WO1995027781A1 (en) | 1995-10-19 |
| AU683286B2 (en) | 1997-11-06 |
| AU7312394A (en) | 1995-10-30 |
| JP2002085082A (ja) | 2002-03-26 |
| CN1073154C (zh) | 2001-10-17 |
| PT775199E (pt) | 2002-08-30 |
| EP0775199A1 (de) | 1997-05-28 |
| CN1332240A (zh) | 2002-01-23 |
| US6635252B2 (en) | 2003-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69428214D1 (de) | Transformierender wachstumsfaktor alpha h1 | |
| ATE277078T1 (de) | N-terminal modifizierte polypeptide, und herstellungsprozess | |
| DE60030323D1 (de) | Verfahren und verbindungen zur verlängerung der halbwertzeiten bei der ausscheidung von biowirksamen verbindungen | |
| ES2155819T3 (es) | Inmunoglobulinas hibridas. | |
| ATE159297T1 (de) | Expression von menschlichen serumalbumin in methylotrophischen hefen | |
| NO905264D0 (no) | Fremgangsmaate for fremstilling av biologisk aktivt protein | |
| HUP0103758A2 (hu) | Neurotróf faktorok | |
| FI103506B1 (fi) | Menetelmä syklisten aminohappojohdannaisten valmistamiseksi ja menetelmässä käytettävä välituote | |
| DE3588095D1 (de) | Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung | |
| ATE501254T1 (de) | P- selectin ligandenprotein | |
| DE69430326D1 (de) | Superoxid dismutase-4 | |
| DE69130466D1 (de) | Basen-Tumorzellen Behandlungsverfahren | |
| FI902017A0 (fi) | Foerfarande foer rengoering av protein. | |
| DE59608422D1 (de) | Verfahren zur Herstellung von Poly(diorganosiloxanen), Mischungen, enthaltend diese Poly(diorganosiloxane) und deren Verwendung | |
| ATE69955T1 (de) | Verfahren zur herstellung vom therapeutisch nutzbaren fviii/vwf-komplex und resultierende produkte. | |
| CA2128215A1 (en) | Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy | |
| ATE331032T1 (de) | Glutamine: fructose-6-phosphat amidotransferase (gfat), ihre herstellung und verwendung | |
| DE68928634D1 (de) | Verfahren zur Herstellung von aktivierten Killer-Monozyten und Verfahren zur Überprüfung ihrer tumoriziden Aktivität | |
| NO983579L (no) | FremgangsmÕte for produksjon av rDSPA <alfa>1 | |
| DE69024999D1 (de) | Verfahren zur Herstellung von 2-Oxindol-1-carboxamiden | |
| DE69116582D1 (de) | Verfahren zur Herstellung von rekombinantem Humaninterferon-beta in reiner Form | |
| KR910016339A (ko) | Pp4-델타, 이의 제조방법 및 용도 | |
| WO2001042292A3 (en) | Secreted polypeptide zsig87 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |